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The Postprandial Effect of Anthocyanins on Cardiovascular Disease Risk Factors: 
a Systematic Literature Review of High-Fat Meal Challenge Studies 
Abstract 
© 2020, Springer Science+Business Media, LLC, part of Springer Nature. Purpose of review: Recurrent 
post-prandial metabolic imbalances are important contributing factors to the development of 
cardiovascular disease (CVD). This study evaluated whether anthocyanin consumption attenuates the 
deleterious postprandial response of high-fat meals on CVD risk factors including blood pressure, 
vascular endothelial function, lipid profile and biomarkers related to oxidative stress, antioxidant status 
and immune response. Recent findings: Five electronic databases were searched up to the period of 1 
February 2020, yielding 13 eligible studies, including randomised or cross-over clinical trials (18–59 years 
of age), using PRISMA guidelines (PROSPERO registration: CRD42019126265). Potential bias was 
assessed using the revised Cochrane risk-of-bias tool for randomised trials. Beneficial effects of 
anthocyanins were reported in biomarkers of oxidative stress and antioxidant status in 6 out of 9 studies, 
and in 3 out of 6 studies for inflammatory response. Two positive results were found concerning 
attenuation of post-prandial endothelial dysfunction, increased triacylglycerol and total cholesterol 
exerted by the high fat meal. Blood pressure and lipoproteins were the parameters with least beneficial 
results. Summary: Our systematic literature review revealed beneficial effects of dietary anthocyanin 
interventions on CVD risk factors following a HFM challenge; however, heterogeneity in results exists. The 
most promising results were for the attenuation of deleterious postprandial effects on oxidative stress 
and antioxidant status, triacylglycerol and total cholesterol concentrations, vascular endothelial function 
and inflammatory biomarkers. Post-prandial changes in blood pressure and lipoproteins were least 
affected by anthocyanins. Further studies are required in order to better elucidate the post-prandial 
effects of anthocyanins and CVD risk factors. 
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Background & aim: Recurrent post-prandial metabolic imbalances are important contributing 27 
factors to development of cardiovascular disease (CVD). The aim of this study is to evaluate 28 
whether anthocyanin consumption attenuates the deleterious postprandial response of high-fat 29 
meals on CVD risk factors including blood pressure, vascular endothelial function, lipid profile 30 
and biomarkers related to oxidative stress, antioxidant status and immune response. 31 
Methods: Five electronic databases were searched up to the period of 1st February 2020, 32 
yielding 13 eligible studies, including randomised or cross-over clinical trials (18-59 years of 33 
age), undertaken using the procedures outlined in the PRISMA statement (PROSPERO 34 
registration: CRD42019126265). Studies were assessed for potential bias using the revised 35 
Cochrane risk-of-bias tool for randomised trials 36 
Results: Beneficial effects of anthocyanins were reported, in one or more biomarkers, for 37 
oxidative stress and antioxidant status in 6 out of 9 studies, and in 3 out of 6 studies for 38 
inflammatory response. Two positive results were found concerning attenuation of the post-39 
prandial endothelial dysfunction, increased triacylglycerol and total cholesterol exerted by the 40 
high fat meal. Blood pressure and lipoproteins were the parameters with least beneficial results.   41 
Conclusion: Despite some positive findings, there was heterogeneity for changes in some CVD 42 
risk factors between studies. The most promising results were for the attenuation of deleterious 43 
postprandial effects on oxidative stress and antioxidant status, triacylglycerol and total 44 
cholesterol concentrations, as well as for vascular endothelial function and inflammatory 45 
biomarkers. The post-prandial changes in blood pressure and lipoproteins were the parameters 46 
least affected by anthocyanin treatment. Further studies are required in order to advance in the 47 
knowledge of how post-prandial changes are associated with CVD incidence and progress, and 48 
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Introduction 86 
Cardiovascular diseases (CVD) are still the number one cause of death globally, 87 
representing 31% of deaths in 2016. Most CVDs can be prevented by addressing and managing 88 
behavioural risk factors such as diet [1]. Several CVD risk factors are associated to the 89 
atherosclerotic process and other vascular dysfunctions closely linked to nutrition [2].  90 
There is an emerging evidence that metabolic imbalances at the postprandial state, 91 
particularly after a high-energy meal rich in fat, are important contributing factors to 92 
development of CVD [3,4]. Overall, the underlying mechanism involves a sharp increase in 93 
triacylglycerol along with an aberrant production of pro-oxidant molecules leading to an 94 
oxidative stress state, which may impair vascular and endothelial functions, as well as mediate 95 
the onset of an inflammatory response, which further contributes to the generation of more free 96 
radicals, thus creating a deleterious vicious cycle [3–5]. Dietary fats comprise heterogeneous 97 
molecules with diverse structures, which affect diverse cell processes such as transcription 98 
regulation, cellular and organelle membrane structure and function, ion channel activity and 99 
electrophysiology. Responses vary depending on both the fatty acid composition of the food 100 
source, as well interactions with accompanying nutrients, the food matrix, and how it has been 101 
processed[6]. Modification of the type of dietary fat in a food or overall meal has been shown 102 
to result in postprandial effects on appetite [7], lipaemia and markers for inflammation and 103 
endothelial activity[8]. 104 
The high-fat meal (HFM) challenge is one way to investigate these imbalances 105 
promoted in a daily basis in Western diets [3]. Thus, this type of studies allows dietetic 106 
therapeutic opportunities to attenuate the harmful effects of aberrant production of pro-oxidant 107 
molecules. Nutrition plays a major role in enhancing endogenous antioxidant defences and 108 
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regulating the inflammatory state [9] and dietary components consumed alongside a high fat 109 
meal may be beneficial in blunting a harmful postprandial response [10]. 110 
Anthocyanins, a subclass of flavonoids, are emerging as a potential therapeutic option 111 
for CVD risk factors[11]. Anthocyanins are the largest class of water-soluble plant pigments, 112 
that are responsible for the blue, purple and red colour of many fruits and vegetables, such as 113 
blueberries, blackberries, red grapes, plums and eggplants [12]. The positive results of 114 
anthocyanins on CVD risk factors are related to its antioxidant and immunomodulatory effects, 115 
thereby attenuating the cooperative and synergistic deleterious effects of oxidative stress and 116 
inflammation in this condition [11,12]. In humans, anthocyanins intake has been associated 117 
with a lower risk of cardiovascular events [13,14], as well as studies using anthocyanins as a 118 
diet intervention have shown improvements in vascular function [15] and in biomarkers related 119 
to oxidative stress [16–19], antioxidant status [17,19–21], lipid profile [22–24] and 120 
inflammatory response [25,26] in both long-term and acute designs. 121 
 To date, there has been no review of the effect of such compounds in studies using a 122 
HFM challenge. In order to address this question, a systematic literature review was undertaken 123 
using the procedures outlined in the PRISMA statement [27] aiming to evaluate if concomitant 124 
consumption of anthocyanins with a HFM attenuates the deleterious postprandial response of 125 
parameters known to be CVD risk factors, including blood pressure, vascular endothelial 126 





Search strategy 132 
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A systematic literature review was undertaken using the procedures outlined in the 133 
PRISMA statement [27]. Five electronic databases were searched up to the period of 1st 134 
February 2020; Medline, Scopus, CINAHL, Web of Science and PubMed. Two researchers 135 
were responsible for studies selection, data extraction, quality assessment and synthesis. The 136 
search strategy was carried out in accordance with the database orientations using Boolean 137 
operators (OR and AND), parenthesis, quotation marks and asterisk. Quotation marks were 138 
used to search for exact terms or expressions; parenthesis were used to indicate a group of 139 
search terms or combine two groups of search terms enabling all possible combinations of 140 
sentences; asterisks were used to search all words derived of the precedent inflected part. The 141 
groups of search terms used were: "endothelium function" or "endothelium dysfunction" or 142 
"laser speckle" or "laser doppler" or "flow-mediated dilatation" or FMD or LSCI or "arterial 143 
stiffness" or "pulse wave velocity" or PWV or "lipid profile" or LDL or VLDL or ox-LDL or 144 
"oxidative stress" or "lipid peroxidation" or "blood pressure" or cytokines or inflammation or 145 
immune or inflammatory or chemokine or adhesion or malondialdehyde or isoprostanes or 146 
nitrite or nitrate or ENO* "nitric oxide") AND ("postprandial" or "postprandial" or "post 147 
prandial" or "meal challenge" or "challenge meal" or "test meal") AND anthocyanins. The 148 
study selection, quality assessment, data extraction and synthesis were conducted by two 149 
researchers independently and then reviewed by all authors. The review was registered with 150 
PROSPERO (CRD42019126265). 151 
 152 
Selection criteria 153 
Selection criteria were formed using the Population Intervention Comparison Outcome 154 
Study design (PICOS) format [27]. The criteria used to screen the titles and abstracts of 155 




Table 1. PICOS (participants, interventions, comparisons, outcomes, and study design) 158 
criteria to define the research question 159 
Parameter Inclusion criteria 
Participants Young adults (18-59 years of age) 
Interventions Dietary intervention with anthocyanins in whole food or purified extract 
Comparators A comparison group receiving a control intervention 
Outcomes 
CVD risk factors including blood pressure, lipid profile, vascular and 
endothelial function, biomarkers related to inflammation, oxidative 
stress and antioxidant status 
Study design 
Randomised or cross-over clinical trials with high fat meal challenge 
for all groups. 
 160 
Only articles published in English were included. Exclusion criteria: mean age of 161 
participants <18 or >59 years; no nutritional information of the HFM, placebo or dietary 162 
intervention; other conditions besides the HFM challenge. Reference lists of included articles 163 
were screened for further studies that may have been missed in initial database search.  164 
 165 
 Data extraction 166 
Two independent reviewers extracted data and cross checked results to ensure 167 
consistency. The following data were extracted from each study and reported in a summary 168 
table; year of publication, author(s), participant demographics, sample size, anthocyanin source 169 
and dose, control used, test meal and study outcomes (Table 2). Authors were contacted if 170 
further information was required. 171 
 172 
Risk of bias assessment 173 
Studies included in this review were assessed for potential bias using the revised 174 
Cochrane risk-of-bias tool for randomised trials [28]. Two researchers independently reviewed 175 
each study, performing evaluation across five risk-of-bias domains, with each domain rated 176 
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either low risk, high risk or some concern of bias. The prescribed algorithm was used to 177 




Study selection 182 
A total of 9135 articles returned through database searching. 1464 duplicates were 183 
removed and 7671 articles were excluded during title and abstract screening (Figure 1). The 184 
full-text of the remaining 29 articles were accessed and evaluated according the study selection 185 
criteria. Sixteen articles were excluded as they did not meet all criteria and the remaining 13 186 
studies were eligible for the review.  187 
 188 
Characteristics of studies included in review 189 
The characteristics of the 13 studies reviewed are summarised in Table 2. All studies 190 
included had a cross-over design with a wash-out period ranging from 4 to 28 days, of which 191 
four were double-blinded [29–32], seven were single-blinded [26,33–38] and two did not 192 
present blind strategies [39,40]. The mean age of subjects involved in included studies ranged 193 
from 20.2 to 50.9 years and five studies were conducted only in male subjects [29,32,33,37,40], 194 
while all other recruited men and women. The majority of studies were conducted on healthy 195 
individuals, except for one study on subjects with an atherosclerosis-prone phenotype [33], one 196 
on subjects with obesity and insulin resistance phenotype [35] and another one with participants 197 
with at least one CVD risk factor [39]. In relation to the dose of anthocyanins used in the 198 
intervention, six studies used a dose <100mg [26,30,31,33,36,39] and four studies used doses 199 
>100mg [29,32,37,38], while two studies used three different doses [35,40] and one study used 200 
two different doses [34] within both ranges. Overall, the dose ranged from 11.2 to 1530mg of 201 
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anthocyanins. The fat content within meal challenges were <40g in four studies [26,30,34,35] 202 
and >40g in nine studies [29,31–33,36–40]. Concerning fat content as % of energy, the meal 203 
challenges in six studies provided >50% of energy from fats[29,30,32,33,39,40], while seven 204 
studies provided <50% energy from fats[26,31,34–38]. The main type of fats within the 205 
challenge meals were derived from animal products with high content of saturated fats such as 206 
cream, sausages, cheese, fried potatoes, bacon, eggs and butter. There were no relevant source 207 
of omega-3 fatty acids included in any of the challenge meals. All studies used a macronutrient 208 
matched placebo in the control arm. In eleven studies [26,29–37,39], either a beverage, yoghurt  209 
 210 




or smoothie was used, while two studies[38,40] provided meals without incorporating 213 
the freeze-dried source of anthocyanins. One study used water as an additional control 214 
treatment[39], while another also matched the content of vitamin C in the placebo[32]. 215 
 216 
Risk of bias 217 
The overall risk of bias was judged as “low risk” for ten studies [26,29,30,32,34–36,38–218 
40], while three studies [31,33,37] were judged as having “some concern” due to ranking as 219 
such in one or more risk domains (Table 3). Among the studies that were identified as having 220 
“some concern” regarding risk of bias, two studies [33,37] had missing information on domain 221 
1 (risk of bias arising from the randomization process) and one study [31] had missing 222 
information on domain 3 (risk of bias due to missing outcome data) [28]. 223 
 224 
Outcomes  225 
The outcomes analysed in the included studies were blood pressure, lipid profile, 226 
vascular and endothelial function, as well as biomarkers related to inflammation, oxidative 227 
stress and antioxidant status (Table 2). The postprandial response of such outcomes were 228 
analysed after the intake of the high-fat meal challenge, which means that a significant decrease 229 
may actually mean an attenuation of an increase pattern. Three studies measured blood pressure 230 
[29,38,39] before and after the HFMC, none of which found significant changes in systolic 231 
blood pressure. One study found a reduction in diastolic blood pressure in the anthocyanins 232 
intervention group (p=0.0045), while an absence of effect was observed in the other two arms 233 
administering water or a matched anthocyanins-free placebo [39]. Vascular and endothelial 234 
function were evaluated by three studies [29,38,39]. Alqurashi et al. [29] assessed endothelial 235 
function in the brachial artery by flow-mediated dilatation (FMD) with a postprandial increase 236 
of 1.4% versus 0.4% at 2h (p=0.001) and an increase of 0.8% versus a decrease of -0.3% at 6h 237 
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Table 2. High-fat meal challenge studies analysing cardiovascular risk factors 238 




Healthy male adults 
(n=23), mean age 46yr 
± 1.9, BMI 27.6kg/m2 
± 0.4 
Açai smoothie: 150g 
frozen açai pulp, 50g 
banana, 155.1Kcal, 
8.5g fat, 2.4g PTN, 








(60.6% from fat), 
58.5g fat, 74.4g 
CHO, 11.4g PTN  
Blood pressure: ↔ 
FMD: ↑ 1.4%, p=0.001 at 2h and ↑ 0.8%, 
p<0.001 at 4h. 
Plasma total oxidant capacity (peroxide 
concentrations): ↓ area under the curve over 7h, 
p=0.02 
Cerletti et al. 
2014, 
Italy[39] 
Adults (n=18: 9 
females, 9 males), 36.9 
± 10.5yr, BMI 26.8 




smoking, high serum 
cholesterol or TG 
levels 
Red orange juice: 
53.1mg anthocyanins 
a)Blonde orange 
juice; b) water 
890 Kcal (52.6% 
from fat), 52g fat, 
25g PTN, 81g 
CHO 
Augmentation index (vascular stiffness): ↓ 
2.18 ± 19.26 to -6.11 ± 11.90, p=0.0030 
Reactive hyperemia index (vascular 
reactivity): ↔ 
Blood pressure: ↔ (diastolic blood pressure 
within group:↓ p=0.0045) 




et al. 2010, 
USA[26] 
Healthy adults (n=24, 
14 females, 10males) 
BMI 29.2 ±2.3,  
50.9yrs ± 15 








(28.1% from fat), 
30g fat, 36g PTN, 
135g CHO 
 
hsCRP: ↓ 3.1 (SEM 0.1) vs 2.7 (SEM 0.5) 
mg/L, P=0.02 at 6h 
IL-6: ↓ 3.4 (SEM 0.5) vs 4.5 (SEM 0.5) pg/ml, 




Miglio et al. 
2012, 
Italy[30] 
Healhy adults (n=14), 
45yr ± 9, BMI 
26.8kg/m2 ± 2.2 





b) Fruit juice (63% mix 
of  pineapple, 
blackcurrant and plum 
Energy and sugar 
matched placebo, 
66g CHO 
1344 Kcal (54.2% 
from fat), 81g fat, 
104g CHO, 52g 
PTN, 3.1g fibre 
Urinary FRAP: ↑ 35%, p<0.01 
Plasma TRAP: ↑ p<0.05 at 1h, ↑ 8%, p<0.001 
at 2h, ↑ p<0.01 at 4h. 
Plasma FRAP: ↔ 
Plasma uric acid: ↓ p<0.05 at 8h 
Plasma Thiols: ↓ p<0.05 at 0.5, 1, 4 and 8h, ↓ 
p<0.01 







et al. 2016, 
USA[34] 
Healthy adults (n=23, 
18 females, 5 males), 
30yr ± 3yr, BMI 
21.9kg/m2 ± 0.4 
Yoghurt + freeze dried 







Kcal, 0.6g fat, 
45.1g CHO, 1.2g 
PTN, 10g fibre 
 
653 Kcal (40.0% 
from fat), 29g fat, 








Park et al. 
2016, 
USA[35] 
Adults with obesity 
and insulin resistance 
phenotype (n=21, 16 
females, 5 males), 
39.8yr ± 13.8, BMI 
40.2 ± 7.2 
Freeze dried whole 
strawberry powder: a) 
42.2mg anthocyanins; 
b) 87.9mg; c) 154.5mg 
Milk based colour 
and macronutrient 
matched beverage 
967 Kcal (23.6% 
from fat), 25.4g 
fat, 146.2g CHO, 





OxLDL-c: ↓ –3.0 ± 0.8 U/L, p<0.05 
 
Richter et al. 
2017, 
USA[38] 
Healthy adults (n=30, 
13 females, 17 males), 
BMI 31 kg/m2 ± 0.5, 
28yr ± 2.0 
Freeze dried 
strawberry powder:  
163.41mg 





(added to meal) 
1004Kcal (44.8% 
from fat), 50g fat, 
105g CHO, 32g 
PTN, 7g fibre 
 




Augmentation index: ↔ 





Healthy adult males 
(n=9), 20.2yr (18.7-
27.3), BMI 24.6 kg/m2 
(20.7-29.4) 
Berry concentrate: a) 
added on beverage, 
90mg anthocyanins; 
b) added on burger and 
on beverage, 174.3mg 
anthocyanins 
Plain burger and 
water 
527 Kcal (58.9% 
from fat), 48.7g 
PTN, 34.33g fat, 
4.6g CHO 
TAG: ↔ 
MDA: ↓ p<0.05 at all time points for 
intervention “b” and ↓ p<0.05 at 5 and 6h for 
intervention “a” 
PTNcarbonyls: ↓ p<0.05 at 2, 3, 4, 5 and 6h 
for intervention “b” and ↓ p<0.05 at 4 and 6h 
for intervention “a” 
Plasma FRAP: ↔ 






Healthy adults (n= 14, 
9 males and 5 females), 
25yrs ± 4, BMI 
26kg/m2 ± 2 
Freeze dried 






0.8g PTN, 0.1g 
fat, 9.1g CHO 
 
841 Kcal (43.9% 




IL-6: ↓ p=0.048 (intervention consumed before 
the meal) over 10h; ↔ (intervention consumed 
within and after the meal, trend p<0.1) over 10h 




mean age 46.9 ±1.9), 









matched in CHO 
and energy  
853 Kcal (49.3% 
from fat), 46.7 g 
fat, 75.2g CHO, 
32.4g PTN, 4.5g 
fibre  
 
ORAC: ↑ p<0.05 






Peluso et al. 
2011, 
Italy[31] 
Healthy adults, (n=14, 
12 males and 2 
females),  45.1yrs ± 











1344 Kcal (30.0% 
from fat), 184g 
CHO, 44.8g fat, 
49g PTN 
TAG: ↔ 
TC: ↔ [prevented a significant increase 
(p<0.001) observed only at the control group 
over 8h] 
IL-17: ↓ p<0.05 at 4 and p<0.01 at 8h 
IL-6: ↓ 0.5h (p<0.01), 1h (P<0.05) and 2h 
(p<0.001) 
TNF-a: ↓ at multiple time points (p<0.01 at 1h, 
p<0.05 at 2 and 6h, p<0.001 at 4 and 8h) 
 





phenotype (n=11), 37.4 




blackcurrant puree, 9% 
raspberry puree, 7% 
cherry puree, 39% red 










fat, 6.0g PTN, 




(added cream and 
sugar): 1029 Kcal 
(55.8% from fat), 
63.8g fat, 6.0g 
PTN, 107.6g 
CHO, 1.8g fibre 







ORAC: ↑ p<0.040 at 90min and p<0.02 at 120 
min  







Polley et al. 
2019, 
USA[32] 
Healthy adults (22 yrs 







+11mg of vitamin 
C: 166.5Kcal,  
CHO 39.4g; PTN 
2.24g 
Biscuit, sausage 
patty and butter: 
920 Kcal (58.7% 
from fat), 60.0g 






      
Abbreviations and symbols: CHO, carbohydrate; PTN, protein; FMD, flow-mediated dilatation; Kcal, kilocalories; TAG, triacylglycerol; TC, total cholesterol; 239 
HDL-c, high-density lipoprotein cholesterol; LDL-c, low-density lipoprotein cholesterol; OxLDL-c, oxidized low-density lipoprotein cholesterol; hsCRP, high 240 
sensitivity C-reactive protein; FRAP, ferric reducing ability of plasma; TRAP, total radical-trapping antioxidant parameter; ORAC: oxygen radical absorbance 241 










(p<0.001), comparing the intervention with the placebo group, respectively. Cerletti et al. [39] 250 
assessed vascular stiffness through the augmentation index (AI) and vascular reactivity through 251 
the reactive hyperemia index (RHI). The latter did not present significant changes, but there 252 
was a significant decrease (2.18 ± 19.26 to -6.11 ±11.90, p=0.0030) in the AI 3h after the meal 253 
only in the anthocyanins intervention arm [39]. Richter et al. [38] investigated AI and 254 
augmentation pressure through pulse wave analysis and the aortic stiffness assessed by carotid-255 
femoral pulse wave velocity (PWV). None of the parameters were significantly different 256 
between intervention and control arms [38]. 257 
Regarding the lipid profile, ten studies evaluated triacylglycerol (TAG) [31–40], of which one 258 
study found a higher decrease (p=0.0131)  in the intervention group [39] and other study found 259 
a trend(p=0.059) of a decrease 60 minutes after ingestion of the HFMC [33]. Total cholesterol 260 
(TC) was evaluated by five studies [31,33,34,37,39] and two studies found significant changes. 261 
Cerltetti et al. [39] found a reduction (p=0.0339) only in the anthocyanin intervention arm [39], 262 
while Peluso et al. [31] found that the anthocyanins prevented an increase in the intervention 263 
group, therefore a significant increase was only observed in the control group over 8h 264 
(p<0.001) [31]. The studies that measured HDL-c [33,34,37] and LDL-c [33,34,37] did not 265 
find any significant changes.  266 
Among inflammatory markers, six studies evaluated IL-6 [26,31,33–36] 267 
concentrations, of which three [26,31,36] reported significant changes. In one study [26] the 268 
anthocyanin intervention was able to attenuate an increase in IL-6 response six hours after the 269 
HFMC compared to the placebo group [3.4 (SEM 0.5) versus 4.5 (SEM 0.5) pg/ml, P<0.05]. 270 
Similarly, Peluso et al. [31] found a significant attenuation in postprandial IL-6 concentration 271 
at 0.5 (p<0.01), 1 (P<0.05) and 2h (p<0.001) time points [31]. Another study [36] found a trend 272 
to attenuate such response in two groups (consuming the anthocyanins intervention within or 273 
after the HFMC) and a significant decrease in the group consuming the anthocyanins274 
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Domain 1: Risk of bias arising from the 
randomisation process              
Domain 2: Risk of bias due to 
deviations from the intended 
interventions (effect of assignment to 
intervention) 
             
Domain 3: Risk of bias due to missing 
outcome data              
Domain 4: Risk of bias in 
measurement of the outcome              
Domain 5: Risk of bias in selection of 
the reported result              
Overall risk of bias 
             
Symbols:  low risk;   some concern276 
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intervention before the meal (p=0.048). The cytokine TNF-α was evaluated by four studies 
[26,31,33,34] and with one study [31] finding a significant result preventing a postprandial rise 
of TNF-α concentrations at multiple time points (p<0.01 at 1h, p<0.05 at 2 and 6h, p<0.001 at 
4 and 8h). 
There were no significant changes in IL-1β concentrations between treatments cross 
the three studies evaluated this cytokine [26,33,34]. Only one study [26] evaluated hsCRP 
concentrations before and after the HFMC presenting a significant lower concentration 
compared to placebo [3.1 (SEM 0.1) versus 2.7 (SEM 0.5) mg/L, P=0.02]. Still, there was one 
study that measured IL-8 concentration finding not significant results [34] and one study that 
evaluate Il-17 which found a significant postprandial reduction at 4(p<0.05) and 8h(p<0.001) 
time points [31]. 
A large variety of oxidative stress and antioxidant status biomarkers were measured by 
nine studies [29,30,32,33,35–38,40] included in this review. Four studies [33,35,36,38] 
evaluated OxLDL-c concentrations; however, only one study [35] found a significant reduction 
(–3.0 ± 0.8 U/L, p<0.05) in the intervention arm compared to placebo. Plasma malondialdehyde 
(MDA) concentration was measured in two studies [38,40] in which one found that the 
anthocyanins interventions arms were able to prevent postprandial MDA accumulation (p<0.05 
at multiple time points), and the mean value of the area under the curve of was reduced 
compared to placebo [40]. This same study also found a reduction (p<0.05 at multiple time 
points for both anthocyanins interventions) in plasma protein carbonyls and an increase in the 
DPPH (2,2-diphenyl-1-picrylhydrazyl) plasma antioxidant capacity [40]. The ferric reducing 
ability of plasma (FRAP) assay was used to examine antioxidant capacity in was evaluated by 
three studies [30,32,40], but no significant effects of anthocyanin intervention were detected. 
However, Miglio et al. [30] found a 35% increase in the urinary excretion of antioxidants as 
indicated by raised urinary FRAP (P<0.01). This same study found an increase (p<0.05 at 1h, 
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p<0.001 at 2h and p<0.01 at 4h) in plasma total radical-trapping antioxidant parameter (TRAP), 
as well as a significant attenuation in the increase of endogenous antioxidants thiols and uric 
acid (UA) (p<0.05 at 8h). Plasma ascorbic acid (vitamin C) was measured in four studies 
[30,33,37,40], of which one study [33] found an increase in the anthocyanin intervention arm 
(+14 mmol/l, p<0.004) compared to the placebo. The oxygen radical absorbance capacity 
(ORAC) of plasma/serum was evaluated, before and after the HFMC, in five studies 
[32,33,35,37,40], of which two found significant changes. In one study [33], the intervention 
was able to prevent the postprandial decrease in the ORAC of plasma at 90 and 120 min 
following the HFM challenge (p<0.040 and p<0.02, respectively), while another study [37] 
found a significant increase in serum ORAC 1h after the HFMC in intervention group when 
compared to the control (p<0.05). Furthermore, this same study found a significant increase in 
the total antioxidant status (TAS) assay (+4.5%, p=0.05). Lastly, one study [29] measured the 
total oxidant capacity in plasma by assessing the total peroxide concentrations, and found a 
significantly lower incremental area under the curve in the intervention group(p = 0.02). 
 
Discussion 
The results of studies included in this systematic literature review indicate that the 
postprandial state, after exposure to a high fat meal, may provide a useful context to investigate 
acute metabolic changes, from well known lipid responses to complex phenolic compound 
signalling pathways, that contribute to the development of CVD. A wide range of risk factors 
such as blood pressure, lipid profile, vascular and endothelial function, as well as biomarkers 
related to inflammation, oxidative stress and antioxidant status were included as outcomes in 
the acute studies in the review.  
 Despite the lack of positive results in blood pressure, of which only study found a 
significant decrease in diastolic blood pressure [39], vascular and endothelial parameters 
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showed more positive results. It is more likely that such parameters will respond in a higher 
magnitude than blood pressure in acute studies, due to the excess postprandial production of 
pro-oxidant molecules following the HFMC. This may in turn inactivate endothelial dependent 
factors, in particular nitric oxide, leading to impaired vasodilation and the onset of an 
inflammatory response, which further leads to the generation of more free radicals [10,41]. In 
this matter, açai consumption was associated with improvements in endothelial vascular 
function, measured by FMD, in healthy overweight man, which was also followed by an 
increase in total oxidant capacity in plasma, assessed as a measure of total peroxide 
concentrations [29]. The significant improvement in FMD found in this study[29] was 1% 
higher than in controls, a magnitude of effect that has been shown in a meta-analysis to be 
associated with an overall 8 % reduction in CVD risk (RR= 0.92; 95%CI: 0.88; 0.95) for each  
percentage increase [42] . Flow-mediated dilatation is a non-invasive measurement of 
endothelium function that has been associated with CVD risk prediction[42,43]. Another study 
found a decrease in arterial stiffness, measured by AI, after consumption of blood orange juice 
anthocyanins in individual with at least one CVD risk factor (overweight, hypertension, 
smoking, high serum cholesterol or triacylglycerol levels) [39]. 
A recent systematic review evaluated the postprandial inflammatory response to HFM 
challenge, in which IL-6 was stated as the inflammatory marker with the stronger response to 
this stress [44]. IL-6 has a pleiotropic nature showing both anti and pro-inflammatory roles and 
regulating a plethora of immune and metabolic responses, however a high concentration of this 
cytokine has been associated with CVD and mortality [45,46]. Still, IL-6 has a high expression 
on vascular endothelium and the pharmacological inhibition of IL-6 improves endothelial 
function [47]. The inhibitory effect on postprandial IL-6 concentrations found within the 
studies added in this review demonstrates a potential therapeutic effect of anthocyanins for 
CVD [26,31,36]. One possible mechanism that anthocyanins may exert this effect is through 
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decreasing the activity of the NF-κB pathway, which is a transcription factor responsible for 
triggering and regulating inflammatory processes, leading to the expression of pro-
inflammatory cytokines and enzymes [11,48]. Concerning the clinical significance of the 
magnitude of effects reported in the studies that observed benefits associated with anthocyanin 
intake, the significant changes of between 0.34 and 0.90 pg/mL represent changes from 
baseline of >2 SD[26,36] and >3 SD[31]. These results are clinically meaningful considering 
the predictive roles of IL-6 concentration in CVD risk. Hazard ratios of 1.80 are reported 
according to each 1-SD increase in IL-6 for risk of first-ever cerebrovascular events in 
individuals with vascular risk factors without any pre-existing cardiovascular disease[49]. 
Further, a positive predictive value of 100% is reported for coronary artery disease when IL-6 
concentrations exceed 1.0 pg/mL in patients who have an intermediate cardiovascular risk 
profile and chest pain[50]. In a meta-analysis of 17 prospective studies investigating clinical 
coronary outcomes (i.e., myocardial infarction or coronary death), an odds ratio of 1.61 (95% 
CI 1.42–1.83) was found per 2 SD increase in baseline IL-6 [51]. Another meta-analysis of 17 
studies comprising 288,738 healthy individuals reported a significantly higher IL-6 
concentration in CVD cases compared to non-CVD controls (standardized mean difference 
[95% CI]) of 0.14 [0.09, 0.20]/mean difference of 0.36 [0.28, 0.44] pg/mL) [52]. These 
significant changes in IL-6 concentration were found only in studies which the mean BMI of 
participants were >25kg/m2. Overweight and obesity are an independent risk factor for CVD, 
as well as are associated with a low-grade continuous inflammation with high implications in 
the atherosclerotic process. The possibility of regulating this persistent not resolved 
inflammatory state can be crucial in attenuating the progress of the atherosclerosis disease, 
especially in the early stages. This is the same scenario, in which the only study [26] that 
evaluated CRP found a significant reduction of 0.4 (SD 0.1) mg/L in a study population with a 
mean BMI >29kg/m2. This effect reduced the hsCRP concentration in the intervention arm to 
21 
 
values <3.0 mg/L, which is considered a clinical threshold for many cardiovascular conditions, 
including a reduced hospitalisation rate for heart failure in subjects with stable coronary heart 
disease[53]. CRP is also associated with CVD and mortality [54,55], and has been implicated 
in endothelial dysfunction in in vitro and in vivo studies [56,57]. On the other hand, the 
cytokines IL-1β and TNF-α not appear to transiently and/or robustly change in the postprandial 
period after a HFMC, thus a decrease in concentration of these molecules is not likely to occur 
with acute diet interventions [44]. In the present review, the three studies that evaluate IL-1β 
were conducted in healthy normal weight [34], healthy overweight [26] and overweight/obese 
adults with atherosclerosis prone phenotype [33], however none of them found significant 
changes. TNF-α also plays a pleiotropic and major role in CVD, but high concentrations have 
been associated with deleterious effects mainly through vascular dysfunction and atherogenesis 
by many mechanisms such as regulation of the vascular permeability, disruption of the 
endothelial barrier, degradation of glycocalyx, increased production of ROS and decreasing 
NO bioavailability and increase its removal [58,59]. In line with the review by Emerson et al. 
(2017) [44], the studies included in our review found inconsistent changes of TNF-α 
concentrations after the HFMC, i.e. two studies found a decrease [33,34], one an increase [31] 
and other study reported no changes [26]. The study that had a postprandial increase in TNF-α 
concentration was the only one that found a significant lowering effect with the diet 
intervention with anthocyanins [31]. Another relevant finding in this same study was the 
inhibitory effect of on postprandial increase of IL-17, a cytokine with highly pro-inflammatory 
properties that are also associated with CVD, especially with cardiovascular events such as 
stroke and myocardial infarction [60]. There is accumulating evidence that IL-17 it is involved 
in the pathogenesis of cardiovascular diseases by amplifying the inflammation induced by other 
cytokines in synergistic interactions [61]. This cytokine is also positively correlated with 
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OxLDL-c, a molecule with a crucial role in the oxidative stress mediated atherosclerosis 
development.  
OxLDL-c is a key factor in the initiation and progression of atherosclerosis and 
contributes to endothelial dysfunction and plaque destabilization through various mechanisms 
[62]. Among the four studies that measured postprandial concentration of Ox-LDL-c, the only 
study that found a significant reduction was conducted in participants with an obese and insulin 
resistant phenotype [35]. Several other oxidative stress and antioxidant status biomarkers were 
investigated within the added studies in this review, showing the most promising results in 
relation to the effects of anthocyanin intervention on parameters following the HFM challenge. 
MDA is an end product of lipid peroxidation, the radical-initiated oxidative decomposition of 
poly-unsaturated fatty acids [63]. Urquiaga et al. [40] found a reduction in postprandial 
concentration of MDA at multiple time points following two different anthocyanin 
interventions (i.e. added to food or beverage) using a berry concentrate. This same study also 
found a reduction in plasma protein carbonyls and an increase in the DPPH (2,2-diphenyl-1-
picrylhydrazyl) plasma antioxidant capacity [40]. Protein carbonylation is one of the most 
harmful irreversible oxidative protein modifications, and is considered a major hallmark of 
oxidative stress‐related disorders [64]. The DPPH assay is a method that is widely used to test 
the ability of compounds to act as free radical scavengers or hydrogen donors, and therefore 
can be used to evaluate antioxidant activity. Another anti-oxidant assay, the FRAP, (based on 
single electron transfer reaction to evaluate the antioxidant effect of nonenzymatic defense in 
biological fluids) was measured in three studies that reported no significant effect of the 
anthocyanin intervention in plasma [30,32,40]. However, one of these studies found a 35% 
increase in the urinary excretion of antioxidants (P<0.01), which was followed by an increase 
TRAP and an attenuation in the increase of endogenous antioxidants thiols and UA. TRAP 
differs from FRAP as an assay that measures the ability of antioxidants to buffer a reaction 
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probe against peroxidation, and it’s determined by measuring the length of time that oxygen 
uptake is inhibited [65]. Results from both FRAP and TRAP methods have to be carefully 
interpreted considering that FRAP has low specificity in measuring the antioxidant activity of 
many important antioxidants such as ascorbic acid, glutathione and albumin, and that TRAP 
does not necessarily provide a reliable or sensitive measure of the ability of plasma to interfere 
with lipid peroxidation[66].  UA levels are related to oxidative status, especially antioxidant 
capacity and it is well known that high plasma UA levels are strongly associated CVD [67]. 
Taken together, the positive results of these three different oxidative stress biomarkers show a 
relevant anti-oxidant signalling effect of anthocyanins in these studies conducted in healthy 
adults [30,40]. Another relevant biomarker of antioxidant status is vitamin C, which is a readily 
water-soluble and not storable in tissues. Therefore, vitamin C is a good biomarker for short-
term studies [68]. One study added in this review found an increase in plasma vitamin C [33]; 
however, even though the placebo was matched in macronutrients and energy, only the diet 
intervention had a relevant content of vitamin C (122.3 vs 0.3mg). Thus, it is unlikely that the 
plasma concentration of vitamin C was increased due to the anthocyanins. The ORAC of 
plasma/serum, which was evaluated in five studies in this review, appears to be a controversial 
method in regard to its application for in vivo studies, especially after the withdraw of the 
ORAC food database by the USDA in 2010. There is still debate regarding the absorbance and 
breakdown of polyphenols, such as flavonoids and subclasses, into smaller phenolics 
compounds with signalling, anti-inflammatory and anti-oxidant properties [41]. Nevertheless, 
two studies found an increase in plasma ORAC following 60 [33], 90 and 120 [37] minutes 
after the HFMC, and one study also found a significant increase in  TAS [37], another non-
specific assay that assess the overall antioxidant status of a sample.  
The post-prandial response in the lipid profile, when compared to fasting lipids, can 
represent a different and even independent risk factor for CVD [4,23]. The transient lipid and 
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lipoprotein accumulation that occurs in the circulation after a high-fat meal represents the 
individual capacity to metabolize an acute fat input [69] and has been associated as an 
important risk factor in atherosclerosis development [5]. The most relevant postprandial lipid 
marker it is triacylglycerol. It is the lipid with the greatest post-prandial difference from fasting 
lipid markers [23], and has been associated as an independent risk factor for cardiovascular 
events [24]. The results found in our review support these statements, as significant changes 
were only found in triacylglycerol [33,39] concentrations and total cholesterol [31,39], which 
has a composition of 20% triacylglycerol in its formula. 
The choice of placebo in this type of acute study design is important in order to identify 
whether it is indeed the anthocyanin effect that is observed in the results, or whether there are 
other nutrients or food constituents that may be affecting the study outcomes. All studies 
included in this review included a placebo that was matched in macronutrient and fibre content, 
however other nutrients such as vitamin C and other flavonoids that may also play a role in 
postprandial oxidative stress and inflammation are not commonly considered. It is complex, 
and often  impossible, to provide a perfectly matched placebo in food studies of this type, 
therefore results from studies that use different placebos should be carefully scrutinized. 
The most notable challenge and limitation of this study was to address a wide range of 
CVDs biomarkers assessed in this type of acute clinical trial. Overall, the comparison among 
studies had a relevant clinical importance of these metabolic, immune and physiological factors 
that has a synergistic impact on CVDs, however there was a variety of parameters addressed 
with different methods within each of such factors. This made the possibility of meta-analysis 
or other pooled analyses unfeasible, however it not impeded results to be compared narratively. 
Another source of heterogeneity in these studies may have resulted from variability in the HMF 
challenges regarding their macronutrient and energy content, particularly the types of fat, as 
well as the format in which the meals were delivered. Accumulating evidence suggests that the 
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health effects of dietary fats vary[6]. Substitution of  saturated fatty acids from butterfat with 
omega-6 PUFA resulted in a decreased postprandial lipaemia, as well as reduced 
concentrations of IL-6, TNF-α, soluble TNF-α receptors, and soluble vascular cell adhesion 
molecule-1 in overweight men[8]. However, all studies included in this review used animal 
products as the main source of fat, and there were two main types of meals: 1) beverages that 
were enriched with cream and/or milk; or 2) mixed meals including animal products with a 
high content of saturated fat such as sausages, cheese, butter, eggs and bacon. A standardized 
meal for these type of studies would be preferred but may be difficult to implement because of 
cultural diversity in cuisine and dietary patterns. Despite that all included studies were 
conducted in older adults (mean age ranging from 20.2 to 46.9y), there were slightly differences 
in mean BMI with two studies having participants with BMI<25kg/m2 [34,40] six with BMI 
from 25-30kg/m2 [26,29–31,36,39] and three with BMI>30kg/m2 [33,35,38] .Only three studies 
were not conducted in healthy adults, of which participants were not considered healthy due to 
lipidaemia [33], insulin-resistance phenotype [35] or with at least one CVD risk factor [39]. 
However, studies conducted in participants with major chronic diseases with implication on 
CVDs, such as diabetes and hypertension, were not included in this review. Another feature in 
the design of this type of study is that tests are conducted over multiple time following the 
HFM challenge, thereby raising a concern that the number of false positive findings may be 
inflated. For this reason, the interpretation of results found in only one or a few time points, 
and that are not sustained, has to be interpreted with caution. Still, parameters that have been 
used in the studies to investigate oxidative stress and antioxidant status represent a wide range 
of analytical methods, and there is no formal mechanism to establish consensus regarding the 





Despite some positive findings, there was heterogeneity for changes in some CVD risk 
factors between studies. The most promising results were for the attenuation of deleterious 
postprandial effects on oxidative stress and antioxidant status, triacylglycerol and total 
cholesterol concentrations, as well as for vascular endothelial function and inflammatory 
biomarkers. The post-prandial changes in blood pressure and lipoproteins were the parameters 
least affected by anthocyanin treatment. Further studies are required in order to advance in the 
knowledge of how post-prandial changes are associated with CVD incidence and progress, and 
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